Device profile of the Impella 5.0 and 5.5 system for mechanical circulatory support for patients with cardiogenic shock: overview of its safety and efficacy-Reference-Cited by-同舟云学术

Device profile of the Impella 5.0 and 5.5 system for mechanical circulatory support for patients with cardiogenic shock: overview of its safety and efficacy

Published:2021-12-20 Issue: Volume: Page:1-10
ISSN:1743-4440
Container-title:Expert Review of Medical Devices
language:en
Short-container-title:Expert Review of Medical Devices

Author:

Pahuja Mohit¹,Hernandez-Montfort Jaime²,Whitehead Evan H.³,Kawabori Masashi⁴,Kapur Navin K.⁵

Affiliation:

1. Division of Cardiology, Medstar Heart and Vascular Institute, Georgetown University/Washington Hospital Center, Washington, USA

2. Division of Cardiology, Baylor Scott and White Health, Temple, USA

3. Department of Medicine, Massachusetts General Hospital, USA

4. Division of Cardiothoracic Surgery, The Cardiovascular Center, Tufts Medical Center, Boston, USA

5. Division of Cardiology, The Cardiovascular Center, Tufts Medical Center, Boston, USA

Publisher

Informa UK Limited

Subject

Biomedical Engineering,General Medicine,Surgery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17434440.2022.2015323

Reference49 articles.

1. Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis

2. National Trends in the Utilization of Short-Term Mechanical Circulatory Support

3. The Percutaneous Ventricular Assist Device in Severe Refractory Cardiogenic Shock

4. Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock

5. 2015 SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care (Endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology–Association Canadienne de Cardiologie d'intervention)∗

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes among cardiogenic shock patients supported with high-capacity Impella axial flow pumps: A report from the Cardiogenic Shock Working Group;The Journal of Heart and Lung Transplantation;2024-09

2. Extended Duration of Impella 5.5 Support Does Not Adversely Impact Outcomes Following Heart Transplantation: A National Registry Analysis;ASAIO Journal;2024-08-19

3. Bailout Procedure Utilizing Balloon Dilatation for a Percutaneous Micro-axial Flow Pump Entrapped Within a Significantly Calcified Subclavian Artery;Cureus;2024-07-30

4. Prolonged Impella 5.0/5.5 support within different pathways of care for cardiogenic shock: the experience of a referral center;Frontiers in Cardiovascular Medicine;2024-07-02

5. Umbrella review of risk factors for inflammatory bowel disease: a study protocol;BMJ Open;2024-06